Drosophila melanogaster is susceptible to Vibrio cholerae infection

Shin-Young Park1, Yun-Jeong Heo, Kun-Soo Kim

  • 1Department of Life Science, Sogang University, Seoul 121-742, Korea.

Molecules and Cells
|January 13, 2006
PubMed

Insights

Vibrio cholerae infection causes rapid death in Drosophila melanogaster by suppressing antimicrobial peptides (AMPs). Enhancing AMPs like Attacin A boosts survival, suggesting a target for V. cholerae virulence factors.

Area of Science:

  • * Infectious disease research
  • * Drosophila melanogaster as a model organism
  • * Innate immunity and host-pathogen interactions

Background:

  • * Vibrio species are known bacterial pathogens.
  • * Drosophila melanogaster possesses an innate immune system involving antimicrobial peptides (AMPs).
  • * Understanding host-pathogen interactions is crucial for combating bacterial infections.

Purpose of the Study:

  • * To investigate the lethal effects of Vibrio species on Drosophila melanogaster.
  • * To explore the role of antimicrobial peptides (AMPs) in Drosophila's response to Vibrio infection.
  • * To determine if V. cholerae virulence factors target innate immunity pathways.

Main Methods:

  • * Infection of adult Drosophila melanogaster with six Vibrio species.
  • * Monitoring mortality rates and survival times.
  • * Analyzing the transcription of antimicrobial peptides (AMPs) like Attacin A.
  • * Assessing survival rates upon ectopic expression of specific AMPs.

Main Results:

  • * Vibrio cholerae caused 100% mortality in Drosophila within 20 hours.
  • * Avirulent V. vulnificus infection restricted subsequent virulent V. cholerae infection.
  • * V. cholerae infection delayed the transcription of key AMPs, including Attacin A.
  • * Ectopic expression of Attacin A and Metchnikowin significantly enhanced Drosophila survival against V. cholerae.

Conclusions:

  • * Antimicrobial peptides (AMPs) are critical for Drosophila's defense against Vibrio species.
  • * V. cholerae employs virulence factors to evade Drosophila's innate immune response by delaying AMP expression.
  • * Targeting AMP signaling pathways presents a potential strategy for combating V. cholerae infections.